ArticlemAbs

Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.

Huanhuan Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.